The latest price target for Alvotech (NASDAQ:ALVO) was reported by Barclays on December 9, 2025. The analyst firm set a price target for $5.00 expecting ALVO to rise to within 12 months (a possible 24.69% upside). 6 analyst firms have reported ratings in the last year.

The latest analyst rating for Alvotech (NASDAQ:ALVO) was provided by Barclays, and Alvotech initiated their underweight rating.

The last upgrade for Alvotech happened on October 14, 2025 when Morgan Stanley raised their price target to $14. Morgan Stanley previously had an equal-weight for Alvotech.

The last downgrade for Alvotech happened on November 4, 2025 when Deutsche Bank changed their price target from $14 to $8 for Alvotech.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alvotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alvotech was filed on December 9, 2025 so you should expect the next rating to be made available sometime around December 9, 2026.

While ratings are subjective and will change, the latest Alvotech (ALVO) rating was a initiated with a price target of $0.00 to $5.00. The current price Alvotech (ALVO) is trading at is $4.01, which is within the analyst’s predicted range.